Barclays raised the firm’s price target on DexCom (DXCM) to $93 from $90 and keeps an Equal Weight rating on the shares. The firm made “elatively minor changes” to its model to reflect the company’s Q1 results and revised 2025 guidance.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXCM: